
Dennis H. Pedder
Examiner (ID: 14040, Phone: (571)272-6667 , Office: P/3612 )
| Most Active Art Unit | 3612 |
| Art Unit(s) | 2899, 3102, 3106, 3612, 3642 |
| Total Applications | 5987 |
| Issued Applications | 4919 |
| Pending Applications | 211 |
| Abandoned Applications | 929 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12912691
[patent_doc_number] => 20180196073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => Methods of Assessing Future Memory Loss by Measuring Polyunsaturated Fatty Acids
[patent_app_type] => utility
[patent_app_number] => 15/580984
[patent_app_country] => US
[patent_app_date] => 2016-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/580984 | Methods of assessing future memory loss by measuring polyunsaturated fatty acids | Jun 7, 2016 | Issued |
Array
(
[id] => 12794971
[patent_doc_number] => 20180156826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => COMPOSITIONS AND METHODS FOR DIAGNOSIS OF AUTISM SPECTRUM DISORDER
[patent_app_type] => utility
[patent_app_number] => 15/580576
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580576
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/580576 | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF AUTISM SPECTRUM DISORDER | Jun 2, 2016 | Abandoned |
Array
(
[id] => 17221826
[patent_doc_number] => 11174317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Therapeutic agent for mental illness comprising IL-6 inhibitor as active ingredient
[patent_app_type] => utility
[patent_app_number] => 15/579309
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 13235
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579309
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/579309 | Therapeutic agent for mental illness comprising IL-6 inhibitor as active ingredient | Jun 2, 2016 | Issued |
Array
(
[id] => 15247055
[patent_doc_number] => 10509045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-17
[patent_title] => Methods for diagnosing Huntington's disease
[patent_app_type] => utility
[patent_app_number] => 15/577995
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 162
[patent_no_of_words] => 11377
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577995
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/577995 | Methods for diagnosing Huntington's disease | May 26, 2016 | Issued |
Array
(
[id] => 12746254
[patent_doc_number] => 20180140585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => BIOMOLECULES INVOLVED IN ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/577522
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/577522 | Biomolecules involved in Alzheimer's disease | May 26, 2016 | Issued |
Array
(
[id] => 11060995
[patent_doc_number] => 20160257957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/158995
[patent_app_country] => US
[patent_app_date] => 2016-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 42461
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15158995
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/158995 | METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS | May 18, 2016 | Abandoned |
Array
(
[id] => 12773491
[patent_doc_number] => 20180149665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => Metabolic Biomarkers for Memory Loss
[patent_app_type] => utility
[patent_app_number] => 15/575115
[patent_app_country] => US
[patent_app_date] => 2016-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575115
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/575115 | Metabolic biomarkers for memory loss | May 17, 2016 | Issued |
Array
(
[id] => 12261749
[patent_doc_number] => 20180080946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'METHOD FOR DIAGNOSING DISEASES THROUGH OLIGOMER ANALYSIS OF ABNORMALLY AGGREGATED PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/565503
[patent_app_country] => US
[patent_app_date] => 2016-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 3729
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565503
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/565503 | Method for diagnosing diseases through oligomer analysis of abnormally aggregated proteins | May 17, 2016 | Issued |
Array
(
[id] => 11130598
[patent_doc_number] => 20160327573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'Methods for Diagnosing Onset and Monitoring Progression of Huntington\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 15/148498
[patent_app_country] => US
[patent_app_date] => 2016-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11285
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15148498
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/148498 | Methods for Diagnosing Onset and Monitoring Progression of Huntington's Disease | May 5, 2016 | Abandoned |
Array
(
[id] => 13625415
[patent_doc_number] => 20180364259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => ASTROCYTE TRAUMATOME AND NEUROTRAUMA BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 15/570982
[patent_app_country] => US
[patent_app_date] => 2016-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570982
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570982 | Astrocyte traumatome and neurotrauma biomarkers | May 4, 2016 | Issued |
Array
(
[id] => 12212384
[patent_doc_number] => 09909182
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-03-06
[patent_title] => 'Methods for identifying subjects susceptible to charcot-marie-tooth neuropathy type 1C'
[patent_app_type] => utility
[patent_app_number] => 15/145652
[patent_app_country] => US
[patent_app_date] => 2016-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11582
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15145652
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/145652 | Methods for identifying subjects susceptible to charcot-marie-tooth neuropathy type 1C | May 2, 2016 | Issued |
Array
(
[id] => 11123443
[patent_doc_number] => 20160320417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'METHODS AND KITS FOR DETERMINING RISK FOR DEVELOPING ALZHEIMER\'S DISEASE AND PREVENTION OR TREATMENT THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/143234
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12293
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15143234
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/143234 | METHODS AND KITS FOR DETERMINING RISK FOR DEVELOPING ALZHEIMER'S DISEASE AND PREVENTION OR TREATMENT THEREOF | Apr 28, 2016 | Abandoned |
Array
(
[id] => 13481695
[patent_doc_number] => 20180292390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => NOVEL SLICE CULTURES AND METHODS FOR DIAGNOSING NEURONAL DEGENERATION DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/567897
[patent_app_country] => US
[patent_app_date] => 2016-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15567897
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/567897 | NOVEL SLICE CULTURES AND METHODS FOR DIAGNOSING NEURONAL DEGENERATION DISEASES | Apr 24, 2016 | Abandoned |
Array
(
[id] => 11271866
[patent_doc_number] => 20160334413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'THERAPEUTIC AND DIAGNOSTIC METHODS FOR AUTISM SPECTRUM DISORDERS AND OTHER CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/136021
[patent_app_country] => US
[patent_app_date] => 2016-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22098
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15136021
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/136021 | Therapeutic and diagnostic methods for autism spectrum disorders and other conditions | Apr 21, 2016 | Issued |
Array
(
[id] => 12685417
[patent_doc_number] => 20180120305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => Prognostic and Diagnostic Glycan-Based Biomarkers of Brain Damage
[patent_app_type] => utility
[patent_app_number] => 15/565753
[patent_app_country] => US
[patent_app_date] => 2016-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565753
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/565753 | Prognostic and diagnostic glycan-based biomarkers of brain damage | Apr 13, 2016 | Issued |
Array
(
[id] => 12702265
[patent_doc_number] => 20180125921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => USE OF QBP1 PEPTIDE FOR THE INHIBITION OF MEMORY CONSOLIDATION
[patent_app_type] => utility
[patent_app_number] => 15/565409
[patent_app_country] => US
[patent_app_date] => 2016-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565409
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/565409 | USE OF QBP1 PEPTIDE FOR THE INHIBITION OF MEMORY CONSOLIDATION | Apr 7, 2016 | Abandoned |
Array
(
[id] => 16925544
[patent_doc_number] => 11047009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Blood biomarkers for suicidality
[patent_app_type] => utility
[patent_app_number] => 15/091706
[patent_app_country] => US
[patent_app_date] => 2016-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 37
[patent_no_of_words] => 17707
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 390
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15091706
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/091706 | Blood biomarkers for suicidality | Apr 5, 2016 | Issued |
Array
(
[id] => 16384443
[patent_doc_number] => 10809271
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries
[patent_app_type] => utility
[patent_app_number] => 15/559001
[patent_app_country] => US
[patent_app_date] => 2016-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50625
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 288
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559001
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/559001 | Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries | Mar 27, 2016 | Issued |
Array
(
[id] => 11270541
[patent_doc_number] => 20160333088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/063775
[patent_app_country] => US
[patent_app_date] => 2016-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 24205
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15063775
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/063775 | METHODS | Mar 7, 2016 | Abandoned |
Array
(
[id] => 12185449
[patent_doc_number] => 20180044386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 15/554890
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5978
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15554890
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/554890 | Peptide | Mar 1, 2016 | Issued |